Beam Therapeutics Inc. (BEAM)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $1.2M
- Oct 16 · Routine
- Form 4 sales
- 90
- On record
- Form 144 notices
- 43
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleRoutineJun 30, 2026 2026
Sold 50,000 shares at $34.90 ($1.7M)
Evans John M., CEO
10b5-1 planSold 4.6% of holdings ($38.3M position)1M shares left1x usual sizeFollows a Form 144Filing
- 2 Form 4 saleRoutineJun 30, 2026 same day
Sold 373 shares at $34.73 ($13k)
Simon Amy, Chief Medical Officer
10b5-1 planSold 0.4% of holdings ($3.6M position)102,363 shares left0.1x usual sizeFiling
- 3 Form 144 noticeNoticeJul 27, 2026 +27 days
Filed to sell 16,677 shares ($429k)
Simon Amy, Officer
10b5-1 plan4.2x usual sizeFiling
- 4 Form 4 saleUnusualJul 27, 2026 same day
Sold 16,667 shares at $25.74 ($429k)
Simon Amy, Chief Medical Officer
10b5-1 planSold 16.3% of holdings ($2.6M position)85,696 shares left4.2x usual sizeFollows a Form 144Filing
- 5 Form 4 saleRoutineOct 1, 2026 +66 days
Sold 187 shares at $24.41 ($5k)
Cavanagh Bethany J, SVP, Finance and Treasurer
10b5-1 planSold 0.4% of holdings ($1.2M position)50,984 shares left0.1x usual sizeFiling
- 6 Form 144 noticeNoticeOct 15, 2026 +14 days
Filed to sell 25,000 shares ($589k)
Evans John M., Officer, Director
10b5-1 plan0.5x usual sizeFiling
- 7 Form 144 noticeNoticeOct 16, 2026 +1 day
Filed to sell 25,000 shares ($600k)
Evans John M., Officer, Director
10b5-1 plan0.5x usual sizeFiling
- 8 Form 4 saleRoutineOct 16, 2026 same day
Sold 50,000 shares at $23.77 ($1.2M)
Evans John M., CEO
10b5-1 planSold 4.6% of holdings ($26.1M position)1M shares left1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales, notices and lockups (133)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | Oct 16, 2026 | Evans John M. | BEAM | CEO | Form 4 sale | 50,000 | $1.2M | 4.6% | Routine | SEC |
| Oct 16, 2026 | Oct 16, 2026 | Evans John M. | BEAM | Officer, Director | Form 144 notice | 25,000 | $600k | Notice | SEC | |
| Oct 15, 2026 | Oct 15, 2026 | Evans John M. | BEAM | Officer, Director | Form 144 notice | 25,000 | $589k | Notice | SEC | |
| Oct 1, 2026 | Oct 2, 2026 | Cavanagh Bethany J | BEAM | SVP, Finance and Treasurer | Form 4 sale | 187 | $5k | 0.4% | Routine | SEC |
| Jul 27, 2026 | Jul 29, 2026 | Simon Amy | BEAM | Chief Medical Officer | Form 4 sale | 16,667 | $429k | 16.3% | Unusual | SEC |
| Jul 27, 2026 | Jul 27, 2026 | Simon Amy | BEAM | Officer | Form 144 notice | 16,677 | $429k | Notice | SEC | |
| Jun 30, 2026 | Jul 2, 2026 | Simon Amy | BEAM | Chief Medical Officer | Form 4 sale | 373 | $13k | 0.4% | Routine | SEC |
| Jun 30, 2026 | Jul 1, 2026 | Evans John M. | BEAM | CEO | Form 4 sale | 50,000 | $1.7M | 4.6% | Routine | SEC |
| Jun 30, 2026 | Jun 30, 2026 | Evans John M. | BEAM | Officer, Director | Form 144 notice | 25,000 | $858k | Notice | SEC | |
| Jun 29, 2026 | Jun 29, 2026 | Evans John M. | BEAM | Officer, Director | Form 144 notice | 25,000 | $887k | Notice | SEC | |
| Jun 26, 2026 | Jun 29, 2026 | Fmr LLC | BEAM | 10% owner | Form 4 sale | 284,860 | $10M | 25.0% | No plan | SEC |
| Apr 14, 2026 | Apr 14, 2026 | Ho Carole | BEAM | Director | Form 144 notice | 87,784 | $2.7M | Notice | SEC | |
| Apr 1, 2026 | Apr 6, 2026 | Evans John M. | BEAM | CEO | Form 4 sale | 30,078 | $739k | 2.8% | Routine | SEC |
| Apr 1, 2026 | Apr 6, 2026 | Simon Amy | BEAM | Chief Medical Officer | Form 4 sale | 6,700 | $165k | 6.1% | Routine | SEC |
| Apr 1, 2026 | Apr 6, 2026 | Cavanagh Bethany J | BEAM | SVP, Finance and Treasurer | Form 4 sale | 3,242 | $80k | 6.0% | Routine | SEC |
| Apr 1, 2026 | Apr 6, 2026 | Bellon Christine | BEAM | Chief Legal Officer | Form 4 sale | 5,956 | $146k | 5.1% | Unusual | SEC |
| Apr 1, 2026 | Apr 6, 2026 | Ciaramella Giuseppe | BEAM | President | Form 4 sale | 11,810 | $290k | 5.1% | Routine | SEC |
| Mar 31, 2026 | Apr 1, 2026 | Evans John M. | BEAM | CEO | Form 4 sale | 50,000 | $1.1M | 4.8% | Routine | SEC |
| Mar 31, 2026 | Mar 31, 2026 | Bellon Christine | BEAM | Officer | Form 144 notice | 20,000 | $438k | Notice | SEC | |
| Mar 31, 2026 | Mar 31, 2026 | Ciaramella Giuseppe | BEAM | Officer | Form 144 notice | 26,250 | $575k | Notice | SEC | |
| Mar 31, 2026 | Mar 31, 2026 | Simon Amy | BEAM | Officer | Form 144 notice | 20,000 | $438k | Notice | SEC | |
| Mar 31, 2026 | Mar 31, 2026 | Evans John M. | BEAM | Officer, Director | Form 144 notice | 66,874 | $1.5M | Notice | SEC | |
| Mar 31, 2026 | Mar 31, 2026 | Evans John M. | BEAM | Officer, Director | Form 144 notice | 25,000 | $569k | Notice | SEC | |
| Mar 30, 2026 | Mar 30, 2026 | Evans John M. | BEAM | Officer, Director | Form 144 notice | 25,000 | $559k | Notice | SEC | |
| Feb 24, 2026 | Feb 26, 2026 | Ciaramella Giuseppe | BEAM | President | Form 4 sale | 35,000 | $1.1M | 15.5% | Routine | SEC |
| Feb 24, 2026 | Feb 24, 2026 | Ciaramella Giuseppe | BEAM | Officer | Form 144 notice | 35,000 | $1.1M | Notice | SEC | |
| Jan 30, 2026 | Feb 2, 2026 | Evans John M. | BEAM | CEO | Form 4 sale | 50,000 | $1.4M | 4.8% | Routine | SEC |
| Jan 30, 2026 | Jan 30, 2026 | Evans John M. | BEAM | Officer, Director | Form 144 notice | 25,000 | $709k | Notice | SEC | |
| Jan 29, 2026 | Jan 29, 2026 | Evans John M. | BEAM | Officer, Director | Form 144 notice | 25,000 | $735k | Notice | SEC | |
| Jan 22, 2026 | Jan 26, 2026 | Cavanagh Bethany J | BEAM | SVP, Finance and Treasurer | Form 4 sale | 6,198 | $217k | 15.1% | Unusual | SEC |
| Jan 22, 2026 | Jan 26, 2026 | Bellon Christine | BEAM | Chief Legal Officer | Form 4 sale | 1,371 | $47k | 1.4% | Routine | SEC |
| Jan 22, 2026 | Jan 22, 2026 | Bellon Christine | BEAM | Officer | Form 144 notice | 1,371 | $47k | Notice | SEC | |
| Jan 20, 2026 | Jan 21, 2026 | Cavanagh Bethany J | BEAM | SVP, Finance and Treasurer | Form 4 sale | 3,034 | $91k | 6.9% | Routine | SEC |
| Jan 15, 2026 | Jan 20, 2026 | Bellon Christine | BEAM | Chief Legal Officer | Form 4 sale | 18,629 | $645k | 16.1% | Unusual | SEC |
| Jan 15, 2026 | Jan 15, 2026 | Bellon Christine | BEAM | Officer | Form 144 notice | 18,629 | $645k | Notice | SEC | |
| Dec 31, 2025 | Jan 5, 2026 | Emany Sravan Kumar | BEAM | Chief Financial Officer | Form 4 sale | 6,294 | $171k | 7.9% | Routine | SEC |
| Dec 31, 2025 | Jan 5, 2026 | Bellon Christine | BEAM | Chief Legal Officer | Form 4 sale | 1,254 | $34k | 1.1% | Routine | SEC |
| Oct 27, 2025 | Oct 29, 2025 | Fmr LLC | BEAM | 10% owner | Form 4 sale | 459 | $12k | 97.0% | Unusual | SEC |
| Oct 2, 2025 | Oct 3, 2025 | Evans John M. | BEAM | CEO | Form 4 sale | 50,000 | $1.2M | 4.8% | Routine | SEC |
| Oct 2, 2025 | Oct 2, 2025 | Evans John M. | BEAM | Officer, Director | Form 144 notice | 25,000 | $616k | Notice | SEC | |
| Oct 1, 2025 | Oct 3, 2025 | Cavanagh Bethany J | BEAM | SVP, Finance and Treasurer | Form 4 sale | 467 | $11k | 1.0% | Routine | SEC |
| Oct 1, 2025 | Oct 3, 2025 | Bellon Christine | BEAM | Chief Legal Officer | Form 4 sale | 373 | $9k | 0.3% | Routine | SEC |
| Oct 1, 2025 | Oct 1, 2025 | Evans John M. | BEAM | Officer, Director | Form 144 notice | 25,000 | $613k | Notice | SEC | |
| Jul 30, 2025 | Aug 1, 2025 | Fmr LLC | BEAM | 10% owner | Form 4 sale | 48,374 | $992k | 2.3% | No plan | SEC |
| Jul 3, 2025 | Jul 3, 2025 | Simon Amy | BEAM | Chief Medical Officer | Form 4 sale | 1,250 | $24k | 1.9% | Routine | SEC |
| Apr 2, 2025 | Apr 3, 2025 | Simon Amy | BEAM | Chief Medical Officer | Form 4 sale | 30,563 | $548k | 31.7% | Unusual | SEC |
| Apr 2, 2025 | Apr 2, 2025 | Simon Amy | BEAM | Officer | Form 144 notice | 20,997 | $372k | Notice | SEC | |
| Apr 1, 2025 | Apr 3, 2025 | Bellon Christine | BEAM | Chief Legal Officer | Form 4 sale | 5,674 | $104k | 4.6% | Routine | SEC |
| Apr 1, 2025 | Apr 3, 2025 | Evans John M. | BEAM | CEO | Form 4 sale | 30,663 | $563k | 3.0% | Routine | SEC |
| Apr 1, 2025 | Apr 3, 2025 | Ciaramella Giuseppe | BEAM | President | Form 4 sale | 7,434 | $136k | 3.8% | Routine | SEC |